Latest Breaking News On - Leland gershell - Page 1 : vimarsana.com

UroGen Pharma Ltd (NASDAQ:URGN) Q1 2024 Earnings Call Transcript

UroGen Pharma Ltd (NASDAQ:URGN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesPaul choiWilliam huangElizabeth barrettMatt kaplanVincent perroneMark schoenbergDon kimTara bancroftJeff bovaRaghuram selvarajuLiz barrettLeland gershellUrogen pharma ltdLadenburg thalmann

Xeris Biopharma Holdings, Inc (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Xeris Biopharma Holdings, Inc (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesXeris careconnectionOren livnatKelly closeAllison weyGvoke hypopenLeland gershellXerisol levothyroxineJohn shannonSteven pieperPaul edickDavid amsellemRoanna ruizRohan mathurSteve pieperPiper sandler

Trevi Therapeutics to Participate in Upcoming Conferences

Trevi Therapeutics to Participate in Upcoming Conferences
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSan diego convention centerSan diegoPeter dicpinigaitisKatie mcmanusRosalia scampoliLeland gershellAlyn moriceJacky smithInternational conferenceUniversity of manchesterLife sciences conferencePanel discussionHonorary consultant at manchester universityPanel members

Oppenheimer & Co Inc Announces 34th Annual Healthcare Life Sciences Conference

/PRNewswire/ Oppenheimer & Co. Inc. (Oppenheimer) a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) today.

Justin kimJoseph kuo michael duganJay olsonErical moffettJeff jonesJoel sendekLeland gershellMichael margolisHartaj singhMatt bieglerHaven tower groupYork stock exchangeOppenheimer holdingsOppenheimer coOppenheimer holdings incOppenheimer healthcare equity research analysts

Biotech s First IPO of 2024 Soared Good Times Could Be Ahead for the Stocks

Investor interest in newly-issued biotech stocks has been moribund for years, but the sector’s first IPO of 2024, CG Oncology, suggests that investors might.

United statesJosh nathan kazisOppenheimer leland gershellOppenheimer gershellLeland gershellApogee therapeuticsStructure therapeuticsArticle normalBiotechnology servicesCancer drugsTrusts funds financial vehiclesHealthcare life sciencesSpecialized drugs medicationsExchange traded fundsFinancial servicesInvesting securities